South Texas Accelerated Research Therapeutics (START) — San Antonio, Texas

South Texas Accelerated Research Therapeutics (START) is a clinical research site located in San Antonio, Texas, United States 78229-3307.

Crixeo Health Trust Score: 85/100 (GOOD). This profile has not yet been claimed by the site owner.

South Texas Accelerated Research Therapeutics (START) has participated in 43 clinical trials with 19 currently active.

Therapeutic areas: Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms, Endometrial Neoplasms.

Sponsors: Eli Lilly and Company, Debiopharm International SA, Jounce Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 85/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for South Texas Accelerated Research Therapeutics (START)?

South Texas Accelerated Research Therapeutics (START) has a Crixeo Trust Score of 85/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has South Texas Accelerated Research Therapeutics (START) conducted?

South Texas Accelerated Research Therapeutics (START) has 43 clinical trials on record, with 19 currently active. Their work covers Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms, Endometrial Neoplasms.

Is South Texas Accelerated Research Therapeutics (START) accredited by Crixeo Health?

Yes — South Texas Accelerated Research Therapeutics (START) holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about South Texas Accelerated Research Therapeutics (START)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.